arBtrage CAPITALIZING MARKETS checking… Sign in

Zura Bio Limited

ZURA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.40
▼ -7.4% Today
as of Jun 7, 07:32 ET
Last 30 days -35.85% Apr 28 → Jun 05
$3.25 $3.80 $4.36 $4.92 $5.47 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.67
High
$3.73
Low
$3.25
Volume
$5M
Avg Vol
$927,950
Mkt Cap
$399M
P/E (TTM)
Beta
52w High
$7.44
52w Low
$1.00
Div Yield
Shares Out
$95M

Overview

52-week range
$1.00
$7.44
37% of range
Avg surprise (last 2)
-20.6%
Avg reaction (last 2)
-2.4%
50% positive
Latest IV / EM
499%
EM ±69.1% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.31$-0.99$-0.67$-0.34$-0.02 Actual $-1.31Actual $-0.18Actual $-0.02Actual $-0.17Actual $-0.26Actual $-0.19Est $-0.17Actual $-0.17Actual $-0.21Actual $-0.22Est $-0.17 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-24M$-21M$-18M$-14M$-11M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.22 $-0.17 -29.4% -15.8% -7.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.21 financials
Mon Jun 30, 2025Jun 2025 $-0.17 financials
Thu May 8, 2025Mar/2025 $-0.19 $-0.17 -11.8% +2.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.26 financials
Sun Jun 30, 2024Jun 2024 $-0.17 financials
Sun Mar 31, 2024Mar 2024 $-0.02 financials
Sat Sep 30, 2023Sep 2023 $-0.18 financials
Fri Jun 30, 2023Jun 2023 $-1.31 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-25M$-20M$-18M$-19M$-19M$-12M
Net income$-24M$-18M$-16M$-17M$-21M$-10M
EPS (diluted)$-0.22$-0.21$-0.17$-0.19$-0.26$-0.17

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$226M$109M$139M$154M$171M$176M$188M
Inventory
Total current assets$227M$112M$142M$157M$172M$179M$189M$189M
Total assets$229M$114M$144M$158M$172M$180M$189M$190M
Long-term debt
Total liabilities$12M$12M$25M$19M$21M$20M$18M$17M
Total equity$108M$126M$138M$147M$153M$157M

Implied volatility — last 90 days

494%496%499%501%504% Jun 07 — IV 499% · EM ±69.1%

Sector peers